Thursday May 22, 2025

Type 2 Diabetes Market to Register CAGR 8.4% Growth by 2030 | Eli Lilly and Co.,Merck & Co. Inc,Novo Nordisk AS

Global Type 2 Diabetes Market Size study & Forecast, by Drug Class, by Application and Regional Analysis, 2023-2030, Covid 19 Outbreak Impact research report added by Report Ocean, is an in-depth analysis of market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography. It places the market within the context of the wider Type 2 Diabetes market, and compares it with other markets., market definition, regional market opportunity, sales and revenue by region, manufacturing cost analysis, Industrial Chain, market effect factors analysis, Type 2 Diabetes market size forecast, market data & Graphs and Statistics, Tables, Bar &Pie Charts, and many more for business intelligence. Get the whole report, which includes a chart and more than 100 tables and figures. – Comprehensive Analysis of COVID-19 Market Outbreak Impact and Regional Situation

 Download Free Sample Copy of ‘Type 2 Diabetes market’ Report @

https://reportocean.com/industry-verticals/sample-request?report_id=bw7417

Global Type 2 Diabetes Market is valued approximately at USD 32.32 billion in 2022 and is anticipated to grow with a compounded annual growth rate of more than 8.4% over the forecast period 2023-2030. Type 2 Diabetes, also known as adult-onset diabetes or non-insulin-dependent diabetes is a chronic metabolic disorder characterized by high blood sugar levels. It is the most common form of diabetes accounting for approximately 90% to 95% of all diagnosed cases. Unlike type one diabetes, which is an autoimmune condition where the body fails to produce insulin type two diabetes is characterized by insulin resistance and inadequate insulin production. Increasing number of diabetic patients and growing geriatric population elucidate as the growth drivers of this market during the forecast period.

According to the World Health Organization, diabetes may afflict 537 million adults globally in 2021, with one in ten experiencing other diabetes. According to the World Bank Group in 2022, the world old population was 727 million in 2020, and it is predicted to rise over the next three decades, reaching 1.5 billion in 2050. However, lack of awareness of disease and limited treatment options availability may hamper the growth space of this market. Furthermore, emerging pharma sector and increasing prevalence of type 2 diabetes anticipated to elevate the growth of the Global Type 2 Diabetes Market.

The key regions considered for the Global Type 2 Diabetes Market study includes Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. North America dominated the type 2 diabetes market. The region’s market growth is driven by the increasing prevalence of diabetes, with over 29 million individuals affected, expected to rise to 32 million by 2025. Notably, the United States alone had more than 25 million diabetic patients in 2019. The expansion of the healthcare sector, favorable government regulations, and a growing number of initiatives and favorable reimbursement policies contribute to the overall growth of the type 2 diabetes market in North America. Europe is anticipated to exhibit the highest growth rate among regions. Within Europe, the type 2 diabetes market is primarily dominated by the United Kingdom. The increasing number of patients with type 2 diabetes is a key driver for market growth in the region. Factors such as escalating research and development activities and the rising prevalence of obesity contribute to the demand for type 2 diabetes drugs. Furthermore, enhanced supply chain management presents favorable opportunities for the expansion of the type 2 diabetes market in Europe.

Major market players included in this report are:

  • Amgen Inc.
  • AstraZeneca PLC
  • Boehringer Ingelheim International GmbH
  • Daiichi Sankyo Co. Ltd
  • Eli Lilly and Co.
  • Merck & Co. Inc
  • Novo Nordisk AS
  • Sanofi SA
  • Takeda Pharmaceutical Co. Ltd
  • Novartis AG

Recent Developments in the Market:

In October 2022, Glenmark Pharmaceuticals introduced a novel medication called Zita D, intended for the treatment of patients with type 2 diabetes, particularly those who also have a comorbid condition.

In March 2019, Novo Nordisk announced its plans to invest approximately USD 98 million in the expansion and advancement of its insulin medicine manufacturing facility located in Denmark. The completion of this project is anticipated to occur by the conclusion of 2020.

Global Type 2 Diabetes Market Report Scope:

Historical Data: 2020 – 2021

Base Year for Estimation: 2022

Forecast period: 2023-2030

Report Coverage: Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends

Segments Covered: Drug Class, Application, Region

Regional Scope: North America; Europe; Asia Pacific; Latin America; Middle East & Africa

Customization Scope: Free report customization (equivalent up to 8 analyst’s working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Drug Class:

  • Dipeptidyl Peptidase-4 Inhibitors
  • Glucagon-Like Peptide Receptor Agonists
  • Thiazolidinediones
  • Alpha-Glucosidase Inhibitors
  • Sulfonylureas & Other Insulin Secretagogues
  • Biguanides
  • Sodium Glucose Cotransport 2 Inhibitors

By Application:

  • Glycaemic Control
  • Cardiovascular Safety
  • Hypoglycaemia Avoidance
  • Others

By Region:

  • North America
  • U.S.
  • Canada
  • Europe
  • UK
  • Germany
  • France
  • Spain
  • Italy
  • ROE
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • RoAPAC
  • Latin America
  • Brazil
  • Mexico
  • Middle East & Africa
  • Saudi Arabia
  • South Africa
  • Rest of Middle East & Africa

What our report offers:

  • Executive Summary: A concise overview of the report, highlighting the main points, key findings, and recommendations.
  • Introduction: Sets the context for the report by explaining the purpose, scope, and objectives. It may also include background information on the topic.
  • Methodology: Describes the methods and approaches used to gather data, conduct research, and analyze information for the report. This section provides transparency and credibility to the findings.
  • Findings/Results: Presents the main information, data, and analysis related to the topic. It may include charts, graphs, tables, or other visual aids to support the findings.
  • Analysis and Interpretation: Provides an in-depth examination and interpretation of the findings. It may involve comparing data, identifying trends, and drawing conclusions based on the evidence presented.
  • Discussion: Explores the implications and significance of the findings within the broader context. This section may address challenges, opportunities, and potential solutions related to the subject matter.
  • Recommendations: Offers actionable suggestions based on the analysis and findings of the report. Recommendations should be specific, feasible, and linked to the report’s objectives.
  • References/Citations: Includes a list of sources, references, or citations used in the report. This ensures proper attribution and allows readers to explore the referenced material.
  • Appendices: Supplementary materials such as additional data, charts, or supporting documents that are relevant to the report but not included in the main body.
  • Conclusion: Summarizes the key points discussed in the report and reinforces the main findings.

For more information or any query mail at sales@reportocean.com

Each study, more than 100+ pages, is packed with tables, charts and insightful narrative including coverage on: Report Ocean provides complete tailor-made market reports that deliver vital market information on industry. Our market reports include: Market Sizing and Structuring,  Micro and macro analysis,  Regional dynamics and Operational landscape,  Demographic profiling and Addressable market,  Legal Set-up and Regulatory frameworks,  Profitability and Cost analysis,  Segmentation analysis of Market,  Existing marketing strategies in the market,   Best practice,   GAP analysis,  Competitive landscape,   Leading market players,   Benchmarking,  Future market trends and opportunities – Scenario modeling

Geographical Breakdown: The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the impact and recovery path of Covid 19 for all regions, key developed countries and major emerging markets.

In-Depth Qualitative COVID 19 Outbreak Impact Analysis Include Identification And Investigation Of The Following Aspects: Market Structure, Growth Drivers, Restraints and Challenges, Emerging Product Trends & Market Opportunities, Porter’s Fiver Forces. The report also inspects the financial standing of the leading companies, which includes gross profit, revenue generation, sales volume, sales revenue, manufacturing cost, individual growth rate, and other financial ratios. The report basically gives information about the Market trends, growth factors, limitations, opportunities, challenges, future forecasts, and details about all the key market players.

(Check Our Exclusive Offer: 30% to 40% Discount)

https://reportocean.com/industry-verticals/sample-request?report_id=bw7417

Questions & Answers Market Research/Analysis Report Contains to your following:

  • What is the current size of the market and how is it expected to grow in the future?
  • What are the key drivers influencing market growth?
  • What are the major challenges or constraints faced by market participants?
  • What are the emerging trends and opportunities in the market?
  • Who are the major competitors in the market and what is their market share?
  • What are the key customer segments and their preferences within the market?
  • What are the regional or geographic trends and variations within the market?
  • What are the regulatory and legal factors impacting the market?
  • What are the technological advancements or innovations shaping the market?
  • What are the pricing trends and strategies observed in the market?
  • What are the distribution channels and their effectiveness in reaching the target market?

Inquire more and share questions if any before the purchase on this report at

https://reportocean.com/industry-verticals/sample-request?report_id=bw7417

Key Points Covered in Type 2 Diabetes Market Report:

Table of Contents

Chapter 1. Executive Summary

1.1. Market Snapshot

1.2. Global & Segmental Market Estimates & Forecasts, 2020-2030 (USD Billion)

1.2.1. Type 2 Diabetes Market, by region, 2020-2030 (USD Billion)

1.2.2. Type 2 Diabetes Market, by Drug Class, 2020-2030 (USD Billion)

1.2.3. Type 2 Diabetes Market, by Application, 2020-2030 (USD Billion)

1.3. Key Trends

1.4. Estimation Methodology

1.5. Research Assumption

Chapter 2. Global Type 2 Diabetes Market Definition and Scope

2.1. Objective of the Study

2.2. Market Definition & Scope

2.2.1. Industry Evolution

2.2.2. Scope of the Study

2.3. Years Considered for the Study

2.4. Currency Conversion Rates

Chapter 3. Global Type 2 Diabetes Market Dynamics

3.1. Type 2 Diabetes Market Impact Analysis (2020-2030)

3.1.1. Market Drivers

3.1.1.1. Increasing Number of Diabetes Patients

3.1.1.2. Growing Geriatric Population

3.1.2. Market Challenges

3.1.2.1. Lack of Awareness of Disease

3.1.2.2. Limited Treatment Options Available

3.1.3. Market Opportunities

3.1.3.1. Emerging Pharma Sector

3.1.3.2. Increasing Prevalence of Type 2 Diabetes

Chapter 4. Global Type 2 Diabetes Market: Industry Analysis

4.1. Porter’s 5 Force Model

4.1.1. Bargaining Power of Suppliers

4.1.2. Bargaining Power of Buyers

4.1.3. Threat of New Entrants

4.1.4. Threat of Substitutes

4.1.5. Competitive Rivalry

4.2. Porter’s 5 Force Impact Analysis

4.3. PEST Analysis

4.3.1. Political

4.3.2. Economic

4.3.3. Social

4.3.4. Technological

4.3.5. Environmental

4.3.6. Legal

4.4. Top investment opportunity

4.5. Top winning strategies

4.6. COVID-19 Impact Analysis

4.7. Disruptive Trends

4.8. Industry Expert Perspective

4.9. Analyst Recommendation & Conclusion

……..and view more in complete table of Contents

Browse Premium Research Report with Tables and Figures at @ https://reportocean.com/industry-verticals/sample-request?report_id=bw7417

Thanks for reading this article; you can also get individual chapter wise section or region wise report version like North America, Europe or Asia.

About Report Ocean:

We are the best market research reports provider in the industry. Report Ocean believe in providing the quality reports to clients to meet the top line and bottom line goals which will boost your market share in today’s competitive environment. Report Ocean is “one-stop solution” for individuals, organizations, and industries that are looking for innovative market research reports.

Get in Touch with Us:

Report Ocean

Email: sales@reportocean.com

Address: 500 N Michigan Ave, Suite 600, Chicago, IIIinois 60611 – UNITED STATES

Tel: +1 888 212 3539 (US – TOLL FREE)

Website: https://www.reportocean.com/

Blog: https://reportoceanblog.com/

Leave a Reply

Your email address will not be published. Required fields are marked *

Back to Top